Suzhou Jiecheng Medical Secures FDA BDD for Transvascular Aortic Valve Treatment
Suzhou Jiecheng Medical Technology Co., Ltd has announced that it has obtained Breakthrough Devices Designation...
Suzhou Jiecheng Medical Technology Co., Ltd has announced that it has obtained Breakthrough Devices Designation...
EnChannel Medical, a Guangzhou-based electrophysiology platform company, has reportedly secured RMB 200 million (USD 28...
China’s Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has announced that its transcatheter valve...
US-based Riparian Pharmaceuticals, Inc., a biotechnology company focused on cardiovascular diseases and co-incubated by Viva...
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced a cooperation framework and service framework...
Swiss pharmaceutical major Novartis AG (NYSE: NVS) has reported its financial results for the second...
Shanghai Xinhengrui Medical Technology Co., Ltd, a manufacturer of heart failure devices, has successfully raised...
China-based Sino Medical Sciences Technology Inc., (SHA: 688108) has announced receiving market approval for its...
Ningbo-based structural heart disease intervention device manufacturer, Jenscare Scientific Co., Ltd (HKG: 9877), has announced...
The Center for Drug Evaluation (CDE) has indicated on its website that China-based biotech firm...
China-based Sino Medical Sciences Technology Inc., (SHA: 688108) has announced that it has received market...
China-based Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607) has announced that the National Medical Products...
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced a memorandum of understanding (MoU) with...
The National Medical Products Administration (NMPA) has granted marketing approval for the “coronary artery interventional...
Shenzhen Abrobo Medical Robot Co, Ltd has reportedly raised RMB 100 million via a Series...
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276) has separately announced receiving clinical trial approvals...
China-based Shanghai MicroPort Endovascular MedTech Co., Ltd (SHA: 688016) has announced plans to raise up...
China-based HighTide Therapeutics Inc. (HKG: 2511) has announced that its Phase II study for the...
China-based Grand Pharmaceutical Group Limited (HKG: 0512) has announced that its Novasight Hybrid System, a...
Peijia Medical Limited (HKG: 9996), a leading China-based medical device company, has announced the successful...